Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation
- 1 April 1991
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 31 (1), 65-69
- https://doi.org/10.1016/0167-5273(91)90269-u
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986
- Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzolineBritish Journal of Pharmacology, 1986
- Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardiaThe American Journal of Cardiology, 1986
- Conversion of supraventricular arrhythmias to sinus rhythm using flecainideEuropean Heart Journal, 1985
- Antiarrhythmic effects of cibenzolineAmerican Heart Journal, 1985
- Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardiasEuropean Heart Journal, 1985
- Successful treatment of atrial tachycardias with flecainide acetate.Heart, 1985
- Effect of Intravenous Flecainide on Atrial Vulnerability in ManDrugs, 1985
- Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmiasJournal of the American College of Cardiology, 1984
- EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIABritish Journal of Pharmacology, 1982